Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYZK4776
Stock Name / FundiShares Healthcare Innovation UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerDRDR(GBX) LSE
ETF Ticker2B78(EUR) F
ETF Ticker2B78.DE(EUR) CXE
ETF TickerDRDR.LS(GBX) CXE
ETF TickerHEAL.AS(EUR) CXE
ETF TickerHEAL.LS(USD) CXE
ETF TickerHEALz(USD) CXE
ETF TickerHEAL(EUR) ETF Plus
ETF TickerDRDR.L(GBP) LSE

Holdings detail for HRMY

Stock NameHarmony Biosciences Holdings
TickerHRMY(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS4131971040

Show aggregate HRMY holdings

News associated with HRMY

Harmony Biosciences Holdings Breaks Below 200-Day Moving Average - Notable for HRMY
In trading on Tuesday, shares of Harmony Biosciences Holdings Inc (Symbol: HRMY) crossed below their 200 day moving average of $34.34, changing hands as low as $33.45 per share. Harmony Biosciences Holdings Inc shares are currently trading off about 6.4% on the day. The chart - 2025-09-09 12:41:14
Validea Joel Greenblatt Strategy Daily Upgrade Report - 9/5/2025
The following are today's upgrades for Validea's Earnings Yield Investor model based on the published strategy of Joel Greenblatt. This value model looks for companies with high return on capital and earnings yields.HARMONY BIOSCIENCES HOLDINGS INC (HRMY) is a mid-cap value stock - 2025-09-05 06:14:36
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Sold by Maryland State Retirement & Pension System
Maryland State Retirement & Pension System lowered its position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 13.2% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 11,165 shares of the company’s stock after selling 1,693 shares during the period. Maryland […] - 2025-08-17 05:17:01
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives $51.00 Average Price Target from Brokerages
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) has earned an average recommendation of “Buy” from the ten ratings firms that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation, eight have given a buy recommendation and one has given a strong buy recommendation to […] - 2025-08-13 03:14:50
Harmony Biosciences (NASDAQ:HRMY) Rating Lowered to Hold at Wall Street Zen
Wall Street Zen cut shares of Harmony Biosciences (NASDAQ:HRMY – Free Report) from a buy rating to a hold rating in a research note issued to investors on Saturday morning. Several other research analysts have also issued reports on HRMY. Needham & Company LLC reiterated a “buy” rating and issued a $49.00 price target on […] - 2025-08-12 04:34:55
Validea Joel Greenblatt Strategy Daily Upgrade Report - 8/7/2025
The following are today's upgrades for Validea's Earnings Yield Investor model based on the published strategy of Joel Greenblatt. This value model looks for companies with high return on capital and earnings yields.GRIFFON CORP (GFF) is a mid-cap value stock in the Appliance &am - 2025-08-07 06:54:43
Arizona State Retirement System Purchases 737 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Arizona State Retirement System grew its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 6.4% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,261 shares of the company’s stock after buying an additional 737 […] - 2025-07-23 05:44:46
Bank of New York Mellon Corp Has $8.70 Million Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Bank of New York Mellon Corp lowered its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 1.3% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 262,238 shares of the company’s stock after selling 3,401 shares during the quarter. Bank of New York Mellon Corp’s holdings in Harmony Biosciences were worth […] - 2025-07-22 06:49:00
Truist Financial Begins Coverage on Harmony Biosciences (NASDAQ:HRMY)
Research analysts at Truist Financial initiated coverage on shares of Harmony Biosciences (NASDAQ:HRMY – Get Free Report) in a report released on Monday, MarketBeat.com reports. The brokerage set a “buy” rating and a $48.00 price target on the stock. Truist Financial’s price target would indicate a potential upside of 36.17% from the company’s current price. […] - 2025-07-22 04:58:48
Louisiana State Employees Retirement System Sells 500 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Louisiana State Employees Retirement System trimmed its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 2.7% in the first quarter, Holdings Channel reports. The firm owned 18,000 shares of the company’s stock after selling 500 shares during the quarter. Louisiana State Employees Retirement System’s holdings in Harmony Biosciences were worth $597,000 as […] - 2025-07-21 05:16:49
Principal Financial Group Inc. Buys 4,753 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Principal Financial Group Inc. lifted its position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 2.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 213,416 shares of the company’s stock after purchasing an additional 4,753 shares during the […] - 2025-07-16 04:38:44
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives $53.63 Consensus PT from Brokerages
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) has received a consensus rating of “Buy” from the eight research firms that are covering the stock, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12-month target price […] - 2025-06-24 02:36:53
Exchange Traded Concepts LLC Takes Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Exchange Traded Concepts LLC acquired a new stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 30,256 shares of the company’s stock, valued at approximately $1,004,000. Exchange Traded Concepts LLC owned 0.05% of Harmony […] - 2025-06-20 05:16:57
Validea Joel Greenblatt Strategy Daily Upgrade Report - 6/13/2025
The following are today's upgrades for Validea's Earnings Yield Investor model based on the published strategy of Joel Greenblatt. This value model looks for companies with high return on capital and earnings yields.CUREVAC BV (CVAC) is a small-cap value stock in the Biotechnolog - 2025-06-13 06:35:45
Harmony Biosciences Holdings (HRMY) Shares Cross Below 200 DMA
In trading on Thursday, shares of Harmony Biosciences Holdings Inc (Symbol: HRMY) crossed below their 200 day moving average of $34.67, changing hands as low as $34.50 per share. Harmony Biosciences Holdings Inc shares are currently trading down about 1.6% on the day. The char - 2025-06-05 12:53:08
Squarepoint Ops LLC Has $582,000 Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Squarepoint Ops LLC boosted its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 125.6% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 16,901 shares of the company’s stock after purchasing an additional 9,411 shares during the period. Squarepoint Ops LLC’s holdings in Harmony Biosciences […] - 2025-06-04 05:06:50
Universal Beteiligungs und Servicegesellschaft mbH Invests $3.24 Million in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 94,011 shares of the company’s stock, valued at approximately $3,235,000. Universal Beteiligungs und Servicegesellschaft mbH owned […] - 2025-06-03 05:10:48
Nuveen Asset Management LLC Has $7.31 Million Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Nuveen Asset Management LLC lifted its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 4.0% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 212,351 shares of the company’s stock after buying an additional 8,193 shares during the quarter. Nuveen Asset Management LLC’s holdings in Harmony Biosciences were worth […] - 2025-05-30 05:00:50
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Bought by Two Sigma Advisers LP
Two Sigma Advisers LP grew its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 21.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 98,900 shares of the company’s stock after buying an additional 17,700 shares during the quarter. Two […] - 2025-05-27 06:37:02
ProShare Advisors LLC Increases Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
ProShare Advisors LLC grew its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 47.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 14,190 shares of the company’s stock after purchasing an additional 4,534 shares during the period. […] - 2025-05-27 06:00:51
Bank of America Corp DE Lowers Stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Bank of America Corp DE lessened its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 35.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 202,508 shares of the company’s stock after selling 113,458 shares during the quarter. Bank […] - 2025-05-27 05:16:49
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Average Rating of “Buy” by Analysts
Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) have been given an average rating of “Buy” by the nine brokerages that are currently covering the company, Marketbeat reports. Eight research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average […] - 2025-05-27 02:48:52
Comerica Bank Has $464,000 Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Comerica Bank grew its position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 27.6% in the fourth quarter, HoldingsChannel reports. The fund owned 13,495 shares of the company’s stock after acquiring an additional 2,919 shares during the period. Comerica Bank’s holdings in Harmony Biosciences were worth $464,000 as of its most […] - 2025-05-16 05:20:57
Needham & Company LLC Reaffirms Buy Rating for Harmony Biosciences (NASDAQ:HRMY)
Harmony Biosciences (NASDAQ:HRMY – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at Needham & Company LLC in a report issued on Tuesday,Benzinga reports. They presently have a $49.00 target price on the stock. Needham & Company LLC’s price target suggests a potential upside of 46.44% from the stock’s previous close. […] - 2025-05-08 04:40:44
Harmony Biosciences (NASDAQ:HRMY) Shares Gap Up Following Better-Than-Expected Earnings
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report)’s share price gapped up before the market opened on Tuesday following a stronger than expected earnings report. The stock had previously closed at $29.96, but opened at $31.11. Harmony Biosciences shares last traded at $31.61, with a volume of 147,182 shares changing hands. The company reported […] - 2025-05-08 02:25:26
How The Pieces Add Up: IJR Headed For $129
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-05 08:51:52
Analysts Set Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Target Price at $52.44
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) has earned a consensus recommendation of “Buy” from the nine analysts that are presently covering the company, Marketbeat.com reports. Nine investment analysts have rated the stock with a buy recommendation. The average twelve-month target price among brokers that have updated their coverage on the stock in […] - 2025-05-05 02:49:06
Barclays PLC Increases Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Barclays PLC grew its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 31.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 100,872 shares of the company’s stock after purchasing an additional 24,010 shares during the […] - 2025-04-29 05:22:55
UBS Group Issues Pessimistic Forecast for Harmony Biosciences (NASDAQ:HRMY) Stock Price
Harmony Biosciences (NASDAQ:HRMY – Free Report) had its price target lowered by UBS Group from $55.00 to $48.00 in a research note released on Monday, MarketBeat.com reports. UBS Group currently has a buy rating on the stock. A number of other equities analysts have also commented on the stock. Deutsche Bank Aktiengesellschaft initiated coverage on […] - 2025-04-29 04:28:55
Envestnet Asset Management Inc. Raises Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Envestnet Asset Management Inc. raised its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 2.5% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 53,826 shares of the company’s stock after buying an additional 1,321 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Harmony Biosciences were worth $1,852,000 at […] - 2025-04-28 04:37:03

iShares Healthcare Innovation UCITS ETF USD (Acc) HRMY holdings

DateNumber of HRMY Shares HeldBase Market Value of HRMY SharesLocal Market Value of HRMY SharesChange in HRMY Shares HeldChange in HRMY Base ValueCurrent Price per HRMY Share HeldPrevious Price per HRMY Share Held
2025-11-11 (Tuesday)54,087USD 1,783,789HRMY holding increased by 62741USD 1,783,7890USD 62,741 USD 32.98 USD 31.82
2025-11-10 (Monday)54,087USD 1,721,048HRMY holding increased by 21094USD 1,721,0480USD 21,094 USD 31.82 USD 31.43
2025-11-07 (Friday)54,087USD 1,699,954HRMY holding increased by 26502USD 1,699,9540USD 26,502 USD 31.43 USD 30.94
2025-11-06 (Thursday)54,087USD 1,673,452HRMY holding decreased by -22175USD 1,673,4520USD -22,175 USD 30.94 USD 31.35
2025-11-05 (Wednesday)54,087USD 1,695,627HRMY holding increased by 34074USD 1,695,6270USD 34,074 USD 31.35 USD 30.72
2025-11-04 (Tuesday)54,087USD 1,661,553HRMY holding increased by 75181USD 1,661,5530USD 75,181 USD 30.72 USD 29.33
2025-11-03 (Monday)54,087USD 1,586,372HRMY holding increased by 41106USD 1,586,3720USD 41,106 USD 29.33 USD 28.57
2025-10-31 (Friday)54,087USD 1,545,266HRMY holding decreased by -17848USD 1,545,2660USD -17,848 USD 28.57 USD 28.9
2025-10-30 (Thursday)54,087USD 1,563,114HRMY holding decreased by -22717USD 1,563,1140USD -22,717 USD 28.9 USD 29.32
2025-10-29 (Wednesday)54,087USD 1,585,831HRMY holding decreased by -17308USD 1,585,8310USD -17,308 USD 29.32 USD 29.64
2025-10-28 (Tuesday)54,087USD 1,603,139HRMY holding decreased by -25421USD 1,603,1390USD -25,421 USD 29.64 USD 30.11
2025-10-27 (Monday)54,087USD 1,628,560HRMY holding decreased by -7572USD 1,628,5600USD -7,572 USD 30.11 USD 30.25
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of HRMY by Blackrock for IE00BYZK4776

Show aggregate share trades of HRMY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-10-24SELL-46030.25030.378 30.365USD -13,968 33.34 Profit of 1,370 on sale
2025-09-11BUY23133.42033.760 33.726USD 7,791 34.00
2025-07-08SELL-23032.75033.110 33.074USD -7,607 33.88 Profit of 184 on sale
2025-06-24SELL-23232.06032.460 32.420USD -7,521 34.00 Profit of 366 on sale
2025-06-23SELL-23231.93032.445 32.393USD -7,515 34.01 Profit of 376 on sale
2025-06-20BUY7,41331.89032.600 32.529USD 241,137 34.03
2025-06-11SELL-20035.14036.390 36.265USD -7,253 34.08 Loss of -437 on sale
2025-05-30SELL-20034.50034.610 34.599USD -6,920 34.00 Loss of -120 on sale
2025-05-21BUY20034.50035.520 35.418USD 7,084 33.99
2025-05-14SELL-1,20033.39034.785 34.645USD -41,575 33.97 Loss of -816 on sale
2025-04-30SELL-20029.47029.573 29.563USD -5,913 34.13 Profit of 913 on sale
2025-04-28SELL-20029.36029.800 29.756USD -5,951 34.22 Profit of 893 on sale
2025-04-25SELL-20029.61029.630 29.628USD -5,926 34.27 Profit of 928 on sale
2025-04-11SELL-1,15829.17029.380 29.359USD -33,998 34.76 Profit of 6,251 on sale
2025-04-08SELL-57628.13029.762 29.599USD -17,049 34.97 Profit of 3,091 on sale
2025-04-07SELL-41828.40029.130 29.057USD -12,146 35.04 Profit of 2,502 on sale
2025-03-31SELL-38433.19033.420 33.397USD -12,824 35.20 Profit of 691 on sale
2025-03-21SELL-38235.28035.510 35.487USD -13,556 35.31 Loss of -66 on sale
2025-03-12SELL-19333.60034.410 34.329USD -6,625 35.46 Profit of 218 on sale
2025-02-28SELL-19333.85034.140 34.111USD -6,583 35.72 Profit of 310 on sale
2025-02-25BUY19336.97037.430 37.384USD 7,215 35.78
2025-02-20SELL-19334.89035.405 35.353USD -6,823 35.85 Profit of 96 on sale
2025-02-19BUY38635.32037.055 36.882USD 14,236 35.86
2025-02-18BUY19339.09039.500 39.459USD 7,616 35.80
2024-12-30SELL-37334.06034.520 34.474USD -12,859 34.39 Loss of -32 on sale
2024-12-06SELL-19033.76034.310 34.255USD -6,508 34.50 Profit of 46 on sale
2024-12-04SELL-19034.92035.350 35.307USD -6,708 34.52 Loss of -150 on sale
2024-12-03SELL-38034.50035.410 35.319USD -13,421 34.52 Loss of -305 on sale
2024-11-21SELL-19333.23033.310 33.302USD -6,427 34.41 Profit of 214 on sale
2024-11-20SELL-19832.79033.660 33.573USD -6,647 34.50 Profit of 184 on sale
2024-11-19SELL-19832.48033.216 33.142USD -6,562 34.62 Profit of 293 on sale
2024-11-18SELL-76433.07033.310 33.286USD -25,431 34.72 Profit of 1,094 on sale
2024-11-12SELL-19135.08036.460 36.322USD -6,938 34.69 Loss of -311 on sale
2024-11-07SELL-19134.91035.370 35.324USD -6,747 34.57 Loss of -144 on sale
2024-11-05SELL-38233.41033.580 33.563USD -12,821 34.70 Profit of 435 on sale
2024-10-28SELL-19135.75035.800 35.795USD -6,837 34.48 Loss of -251 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of HRMY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19108,4725,348234,71146.2%
2025-09-18111,0258,894325,98434.1%
2025-09-1795,108100187,88350.6%
2025-09-16128,09712,358317,22640.4%
2025-09-15135,2090300,08245.1%
2025-09-12151,9232,495255,31559.5%
2025-09-11161,5659,535281,36157.4%
2025-09-10113,5953,149207,04354.9%
2025-09-09206,18322,917461,81744.6%
2025-09-08186,74962,734443,99742.1%
2025-09-0584,99223,242293,94528.9%
2025-09-04133,57521,855288,00646.4%
2025-09-03241,435124,278394,90361.1%
2025-09-02137,28152,607257,77153.3%
2025-08-2996,24839,096140,24868.6%
2025-08-2897,9100133,98773.1%
2025-08-27104,114500187,48255.5%
2025-08-2657,186093,88160.9%
2025-08-2584,4000146,26357.7%
2025-08-2247,5300213,94922.2%
2025-08-2184,1022,300140,92859.7%
2025-08-2098,6900183,56353.8%
2025-08-1980,0390168,82047.4%
2025-08-1883,964303156,50753.6%
2025-08-1569,4878121,07657.4%
2025-08-1471,337844119,72159.6%
2025-08-1380,92726168,51548.0%
2025-08-1276,33123129,34259.0%
2025-08-1198,526506189,09152.1%
2025-08-0875,5290129,88758.1%
2025-08-0780,0520140,75156.9%
2025-08-0698,3506,300192,17351.2%
2025-08-05267,646547468,85257.1%
2025-08-04151,9880230,05366.1%
2025-08-01111,29534186,98859.5%
2025-07-3175,1870140,32653.6%
2025-07-3092,0850197,55146.6%
2025-07-29103,04338188,11754.8%
2025-07-28122,3000234,86952.1%
2025-07-25111,0750232,33247.8%
2025-07-2476,5830125,41461.1%
2025-07-23107,72219215,18650.1%
2025-07-22258,6511,287348,81674.2%
2025-07-21210,1510270,41377.7%
2025-07-18133,326960251,00353.1%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.